文献速递神经肿瘤

多激素ACTH-GH垂体腺瘤:病例报告与系统文献综述

Plurihormonal ACTH-GH Pituitary Adenoma: Case Report and Systematic Literature Review.
PubMed 文献 · World Neurosurg · 2018-03-06

本文报告一例功能性ACTH-GH微腺瘤的60岁女性病例,并系统检索文献综述多激素垂体腺瘤。文献纳入的17篇文章中仅20%(4/20)患者同时出现两种疾病的临床征象。本例术后出现肾上腺功能不全需激素替代,3年随访临床缓解稳定。

要点

  • 多激素垂体腺瘤占功能性垂体腺瘤的10%-15%,最常见与催乳素和生长激素相关。
  • 文献综述中仅20%(4/20)患者同时表现出两种疾病的临床征象。
  • 本例为60岁女性ACTH-GH微腺瘤,术后肾上腺功能不全需激素替代,3年随访临床缓解稳定。

核心结论

  • 本文报告一例ACTH-GH多激素垂体腺瘤,为既往20例报告病例之外的补充病例。
  • 作者认为对此相对罕见疾病的认识具有临床意义。
  • ACTH-GH多激素垂体腺瘤的细胞起源仍存争议,已提出多种假说。

研究设计与样本

  • 病例报告联合系统文献综述,检索PubMed使用「plurihormonal pituitary adenoma」「ACTH GH pituitary adenoma」「acromegaly AND Cushing's disease」等检索词。
  • 文献综述纳入17篇文章,共20例患者。

主要发现

  • 文献综述中仅20%(4/20)患者同时表现出两种疾病的临床征象。
  • 组织学上19例为由两种不同细胞群组成的垂体腺瘤,仅1例有证据显示单个细胞同时产生ACTH和GH。
  • 本例为60岁女性,偶然诊断垂体微腺瘤;内分泌评估显示胰岛素样生长因子1和GH水平升高,ACTH和皮质醇值在正常范围内;超声心动图记录到心室肥厚。
  • 因肢端肥大症的临床和生化证据,推荐手术;术后因肾上腺功能不全开始激素替代治疗,因血压正常停用抗高血压治疗。
  • 组织学检查显示ACTH-GH多激素垂体腺瘤具有2种不同的分泌细胞群;3年随访时患者临床缓解稳定且不再接受激素替代治疗。

临床怎么用

  • 作者认为对此相对罕见疾病的认识具有临床意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Plurihormonal adenomas (PHAs) represent 10%-15% of all functioning pituitary adenomas. The most frequent hormonal associations are with prolactin and growth hormone (GH). Here we describe a rare case of functional adrenocorticotropic hormone (ACTH) and GH microadenoma and report our findings from a systematic literature review of PHA. METHODS: We searched PubMed using the terms "plurihormonal pituitary adenoma," "ACTH GH pituitary adenoma," and "acromegaly AND Cushing's disease". In the 17 articles that were selected for literature review, only 20% (4/20) of patients presented with clinical signs of both diseases. Histologically, 19 were pituitary adenomas composed of two distinct cell populations, while only in 1 case was there evidence of a single cell producing both ACTH and GH. In the case reported here, a 60-year-old woman was incidentally diagnosed with a pituitary microadenoma. Endocrine assessment documented increased levels of insulin-like growth factor 1 and GH; ACTH and cortisol values were within normal ranges. Echocardiography documented ventricular hypertrophy. Because of clinical and biochemical evidence of acromegaly, surgery was recommended. Postoperatively, hormonal replacement therapy was started because of adrenal insufficiency. Her antihypertensive therapy was discontinued due to evidence of normal blood pressure values. Histological examination revealed an ACTH-GH PHA with 2 distinct populations of secreting cells. At 3-year follow-up, the patient showed stable clinical remission and was no longer receiving hormonal replacement therapy. CONCLUSIONS: This is an additional case to the 20 previously reported cases of ACTH-GH PHA. Awareness of this relatively rare entity is clinically relevant. The cytogenesis of ACTH-GH PHA remains a matter of debate, and several hypotheses have been postulated.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Roca E, Mattogno PP, Porcelli T, et al. Plurihormonal ACTH-GH Pituitary Adenoma: Case Report and Systematic Literature Review. World Neurosurg. 2018. PMID: 29501516. doi:10.1016/j.wneu.2018.02.120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。